Orthopedic fixation technology developer Ossio announced today that it closed a $38.5 million Series C financing round. Growth equity firm MVM Partners led the funding. Current shareholders also participated in the round. “We are delighted to have secured this level of interest and commitment from such an experienced and distinguished medical technology investment firm,” said […]
ossio
FDA clears Ossio’s OssioFiber suture anchors for bone fixation
Ossio announced today that it received the third FDA clearance for its OssioFiber product family in recent months. Woburn, Massachusetts-based Ossio’s latest regulatory nod covers the OssioFiber suture anchors (4.75 mm-5.5 mm) for use in the fixation of suture (soft tissue) to bone in the shoulder, foot/ankle, knee, hand/wrist and elbow in a variety of […]
Ossio raises $22m for bio-integrative bone pins
Ossio said today that it closed a $22 million equity round led by OCV Partners. Existing investors Ortho Vision and Secocha Ventures also contributed to the orthopedic fixation company’s round. The Woburn, Mass.-based company said it plans to use its new funds to “accelerate strategic growth initiatives,” such as new product development, commercialization and talent […]
Ortho dev Ossio wins FDA nod for bio-integrative bone pins
Orthopedic device company Ossio said yesterday that it won FDA 510(k) clearance for its OssioFiber BonePin family of products. The Woburn, Mass.-based company said that products in the OssioFiber BonePin family feature a proprietary bio-integrative material that it claims provides stability and secures bone fixation during healing with no permanent hardware left behind. The company […]